are glp-1 receptor agonists banned by wada 2025 Agonist Market Size & Analysis, 2026-2033 GLP-1 weight-loss drugs are a

& Zinman, B

And by the 1950s amphetamines started being marketed to women as weight-loss pills, a market that grew to over $120 million by the 1960s, one study estimates

More important than supplements

Recent research indicates that while these drugs significantly reduce body weight and adiposity, fat-free mass lost accounts for 25-40% of the total weight lost during therapy, raising concerns about muscle loss, which is vital for overall health and physical function

The concept, described by the authors as computational social listening, has relied on the ability of these models to interpret highly variable patient language and align it with clinically recognised terminology